Partly cloudy this evening, then becoming cloudy after midnight. Slight chance of a rain shower. Low 56F. Winds light and variable..
Partly cloudy this evening, then becoming cloudy after midnight. Slight chance of a rain shower. Low 56F. Winds light and variable.
Updated: September 7, 2025 @ 8:53 pm
semaglutide injector pen GLP-1
FRIDAY, Sept. 5, 2025 (HealthDay News) --Â The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering the United States.
Due to shortages of the FDA-approved GLP-1 drugs, like semaglutide and tirzepatide, which are used for type 2 diabetes and weight management, some patients have used compounded versions of the drugs.
These compounded drugs are not approved by the FDA, and serious concerns with these drugs have been identified, including dosing errors, unapproved salt forms, and adverse events that have led to hospitalization.
The green list includes active pharmaceutical ingredients (APIs) in the GLP-1 drugs that have been inspected by the FDA and are determined to be in compliance with FDA standards. Ingredients not on the green list are subject to detention without examination at the border.
"This is part of the agency's decisive steps to safeguard consumers from illegal GLP-1 active ingredients imported from overseas to ensure patient safety and a secure drug supply chain," the FDA writes in a statement.
According to the FDA, compounded drugs should only be used when an FDA-approved drug does not meet a patient's medical needs. Patients are advised to get a prescription from their doctor and to fill the prescription at a licensed pharmacy or use the FDA's BeSafeRx campaign to determine where to safely buy medications online.
"Americans should be confident that the prescription drugs they take are safe," FDA Commissioner Marty Makary, M.D., M.P.H., said in an agency statement. "By strengthening oversight of imported APIs and cracking down on illegal drugs entering the U.S., we are taking aggressive action to protect consumers from poor-quality or dangerous GLP-1 drugs."
Originally published on healthday.com, part of the BLOX Digital Content Exchange.
Information from the News and our advertisers (Want to add your business to this to this feed?)
Success! An email has been sent to with a link to confirm list signup.
Error! There was an error processing your request.
Sign up to receive notifications when a new Columbia Gorge News e-Edition is published.
Would you like to receive our news updates? Signup today!
Receive weekly updates on obituaries and death notices.
Oregon Capital Press presented by Columbia Gorge News
Receive updates on upcoming promotions and special sections.
Receive weekly updates on local sports news.
Sorry, an error occurred.
Already Subscribed!
Cancel anytime
Thank you .
Your account has been registered, and you are now logged in.
Check your email for details.
Submitting this form below will send a message to your email with a link to change your password.
An email message containing instructions on how to reset your password has been sent to the email address listed on your account.
No promotional rates found.
Secure & Encrypted
Thank you.
Your gift purchase was successful! Your purchase was successful, and you are now logged in.
| Rate: | |
| Begins: | |
| Transaction ID: |
A receipt was sent to your email.
Commented